Cargando…

Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice

Changes have been made to the AnaConDa device (Sedana Medical, Stockholm, Sweden), decreasing its size to reduce dead space and carbon dioxide (CO(2)) retention. However, this also involves a decrease in the surface area of the activated carbon filter. The CO(2) elimination and sevoflurane (SEV) ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos-Vidal, Jose Miguel, Merino, María, González, Rafael, García, Cristina, Rey, Saleta, Pérez, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222112/
https://www.ncbi.nlm.nih.gov/pubmed/30784010
http://dx.doi.org/10.1007/s10877-019-00285-0
_version_ 1783533505856143360
author Marcos-Vidal, Jose Miguel
Merino, María
González, Rafael
García, Cristina
Rey, Saleta
Pérez, Irene
author_facet Marcos-Vidal, Jose Miguel
Merino, María
González, Rafael
García, Cristina
Rey, Saleta
Pérez, Irene
author_sort Marcos-Vidal, Jose Miguel
collection PubMed
description Changes have been made to the AnaConDa device (Sedana Medical, Stockholm, Sweden), decreasing its size to reduce dead space and carbon dioxide (CO(2)) retention. However, this also involves a decrease in the surface area of the activated carbon filter. The CO(2) elimination and sevoflurane (SEV) reflection of the old device (ACD-100) were thus compared with the new version (ACD-50) in patients sedated after coronary artery bypass graft surgery. After ERC approval and written informed consent, 23 patients were sedated with SEV, using first the ACD-100 and then the ACD-50 for 60 min each. With each device, patients were ventilated with tidal volumes (TV) of 5 ml/kg of ideal body weight for the first 30 min, and with 7 ml/kg for the next 30 min. Ventilation parameters, arterial blood gases, Bispectral-Index™ (BIS, Aspect Medical Systems Inc., Newton, MA, USA), SEV concentrations exhaled by the patient (SEV-exhaled) and from the expiratory hose (SEV-lost) were recorded every 30 min. A SEV reflection index was calculated: SRI [%] = 100 × (1 − (SEV-lost/SEV-exhaled)). Data were compared using ANOVA with repeated measurements and Student’s T-tests for pairs. Respiratory rates, tidal and minute volumes were not significantly different between the two devices. End tidal and arterial CO(2) partial pressures were significantly higher with the ACD-100 as compared with the ACD-50. SEV infusion rate remained constant. SEV reflection was higher (SRI: ACD-100 vs. ACD-50, TV 5 ml/kg: 95.29 ± 6.45 vs. 85.54 ± 11.15, p = 0.001; 7 ml/kg: 93.42 ± 6.55 vs. 88.77 ± 12.26, p = 0.003). BIS was significantly lower when using the higher TV (60.91 ± 9.99 vs. 66.57 ± 8.22, p = 0.012), although this difference was not clinically relevant. During postoperative sedation, the use of ACD-50 significantly reduced CO(2) retention. SEV reflection was slightly reduced. However, patients remained sufficiently sedated without increasing SEV infusion.
format Online
Article
Text
id pubmed-7222112
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-72221122020-05-14 Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice Marcos-Vidal, Jose Miguel Merino, María González, Rafael García, Cristina Rey, Saleta Pérez, Irene J Clin Monit Comput Original Research Changes have been made to the AnaConDa device (Sedana Medical, Stockholm, Sweden), decreasing its size to reduce dead space and carbon dioxide (CO(2)) retention. However, this also involves a decrease in the surface area of the activated carbon filter. The CO(2) elimination and sevoflurane (SEV) reflection of the old device (ACD-100) were thus compared with the new version (ACD-50) in patients sedated after coronary artery bypass graft surgery. After ERC approval and written informed consent, 23 patients were sedated with SEV, using first the ACD-100 and then the ACD-50 for 60 min each. With each device, patients were ventilated with tidal volumes (TV) of 5 ml/kg of ideal body weight for the first 30 min, and with 7 ml/kg for the next 30 min. Ventilation parameters, arterial blood gases, Bispectral-Index™ (BIS, Aspect Medical Systems Inc., Newton, MA, USA), SEV concentrations exhaled by the patient (SEV-exhaled) and from the expiratory hose (SEV-lost) were recorded every 30 min. A SEV reflection index was calculated: SRI [%] = 100 × (1 − (SEV-lost/SEV-exhaled)). Data were compared using ANOVA with repeated measurements and Student’s T-tests for pairs. Respiratory rates, tidal and minute volumes were not significantly different between the two devices. End tidal and arterial CO(2) partial pressures were significantly higher with the ACD-100 as compared with the ACD-50. SEV infusion rate remained constant. SEV reflection was higher (SRI: ACD-100 vs. ACD-50, TV 5 ml/kg: 95.29 ± 6.45 vs. 85.54 ± 11.15, p = 0.001; 7 ml/kg: 93.42 ± 6.55 vs. 88.77 ± 12.26, p = 0.003). BIS was significantly lower when using the higher TV (60.91 ± 9.99 vs. 66.57 ± 8.22, p = 0.012), although this difference was not clinically relevant. During postoperative sedation, the use of ACD-50 significantly reduced CO(2) retention. SEV reflection was slightly reduced. However, patients remained sufficiently sedated without increasing SEV infusion. Springer Netherlands 2019-02-19 2020 /pmc/articles/PMC7222112/ /pubmed/30784010 http://dx.doi.org/10.1007/s10877-019-00285-0 Text en © Springer Nature B.V. 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Marcos-Vidal, Jose Miguel
Merino, María
González, Rafael
García, Cristina
Rey, Saleta
Pérez, Irene
Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title_full Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title_fullStr Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title_full_unstemmed Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title_short Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
title_sort comparison of the use of anaconda® versus anaconda-s® during the post-operative period of cardiac surgery under standard conditions of practice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222112/
https://www.ncbi.nlm.nih.gov/pubmed/30784010
http://dx.doi.org/10.1007/s10877-019-00285-0
work_keys_str_mv AT marcosvidaljosemiguel comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice
AT merinomaria comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice
AT gonzalezrafael comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice
AT garciacristina comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice
AT reysaleta comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice
AT perezirene comparisonoftheuseofanacondaversusanacondasduringthepostoperativeperiodofcardiacsurgeryunderstandardconditionsofpractice